C4 Therapeutics
CCCC
CCCC
107 hedge funds and large institutions have $1.21B invested in C4 Therapeutics in 2021 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 43 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
15.75% more ownership
Funds ownership: 58.2% → 73.95% (+16%)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
107
Holding in Top 10
5
Calls
$1.92M
Puts
–
Top Buyers
| 1 | +$54.8M | |
| 2 | +$54.4M | |
| 3 | +$43.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$38.6M |
| 5 |
LCM
Laurion Capital Management
New York
|
+$20.7M |
Top Sellers
| 1 | -$80.8M | |
| 2 | -$34.1M | |
| 3 | -$7.21M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$6.15M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$5.31M |